Renee
3 years ago
Shareholders still own shares of ticker TOKIF, except for 20 market days where the ticker is TOKID, with the suffix 'D' signifying a reverse split.
After the 20 market days the ticker will return to TOKIF, unless the company submits a ticker change to FINRA to reflect the new company name.
With the one for 5 reverse split, demonstrated by the suffix 'D' added to the ticker, shareholders now own 20% of the amount of shares owned before the reverse split. Eg., if a shareholder owned 100,000 shares prior to the reverse split they now own 20,000 shares. Theoretically the share price should be up by 5 times the pre-reverse split share price, in theory to equal the same value pre-split to post split.
Eg., 100,000 shares pre-reverse split at 2 cents equals $2,000
20,000 shares post-one for 5 reverse split at 10 cents equals $2,000
Investors do not like reverse splits so investor sentiment will determine the post-reverse split value.
JohnCM
6 years ago
Tree of Knowledge International Corp. Announces Additional Advisory Board Members
By Ryan Allway July 16th, 2018
Toronto, Ontario (FSCwire) – Tree of Knowledge International Corp. (CSE:TOKI) (the “Company” or “TOK”) (formerly Courtland Capital Inc.) is pleased to announce two key additions to its world class Advisory Board. As previously announced, Dr. Michael Smatt and Ambassador Jack Brewer recently joined the Company’s Advisory Board. The mandate of the Advisory Board is to serve as a strategic resource for the Company to advise on healthcare outreach initiatives surrounding CBD and the furtherance of educating both patients and athletes and support the Company’s overall mission. Joining Dr. Smatt and Amb. Brewer on the Advisory Board is life sciences senior executive, Mr. Christopher Kaplan and hemp industry leader and specialist, Ms. Joy Beckerman.
Christopher Kaplan
Mr. Kaplan has over 25 years¹ experience in the life sciences industry with a successful track record that covers R&D, operations, strategy, business development and M&A. In addition, Chris has pioneered new drug development and pursued activities in support of a more personalized medicine approach to patients care. Chris has spent half of his career living and working outside of the US and provides TOK with a strong global biopharma perspective. Chris has held significant Global, European, and US leadership roles at Bristol-Myers Squibb, Novartis, Boehringer-Ingelheim, and most recently as Senior Vice President and Head of North American for Sanofi. Chris holds a Bachelor’s degree from Columbia University and a Master’s degree from the University of Pennsylvania.
Joy Beckerman
Joy Beckerman is the Principal Industrial Hemp Specialist at Hemp Ace International, a New York-based consulting, legal support, expert witness and brokerage firm serving the global community. She is the President of the Hemp Industries Association, founded in 1994 and sits on the National Board of Directors of NORML, founded in 1970. After opening the first hemp store in the State of New York in the early 1990’s, Joy served by appointment as Secretary to the Vermont Hemp Council upon passage of the inaugural Vermont hemp bill in 1996. In mid-1998, she commenced an extensive dual career as a compliance and complex civil litigation paralegal, supporting some of the West Coast’s most distinguished attorneys. Joy is an internationally respected voice, writer and renowned public speaker, instructing on hemp subjects from law and policy, history, agronomy, infrastructure, and cannabinoids to hempcrete, permaculture, and the wide spectrum of hemp industries. She has presented at continuing legal education seminars and at numerous colleges, universities, and conferences over the last nearly quarter of a century. Working directly with legislators and regulators, Joy assists with law and policy-making as a grassroots activist. She is the recipient of the Hemp Industries Association’s 2014 National Hemp Activist of the Year Award, and Seattle Hempfest’s 2016 Regional Cannabis Activist of the Year Award.
Michael Caridi, Chairman and CEO of the Company stated: “It is a great pleasure to announce the additions of Christopher Kaplan and Joy Beckerman to our advisory team. To be able to attract such high level individuals to supplement our world-class team will further support the development of our Company. We aim to utilize the vast networks of these individuals to challenge, support and advise the Company in order to build a global brand and scale up our international foot print.”
ABOUT TREE OF KNOWLEDGE
The Company produces and sells hemp-based cannabidiol (‘CBD”) products in certain jurisdictions in the United States, as well as in Europe, South America, Australia and China. Cannabidiol/CBD is a natural constituent of hemp which is purported to contain wellness properties. TOK’s CBD product line contains EVR Premium Hemp Oil, which is an organically grown and handled, gluten-free, vegan, non-GMO, synergistic compound that is derived from U.S. Department of Agriculture (USDA) approved industrial hemp grown in the United States. TOK currently offers several CBD products, which may be used in connection with the treatment of a number of ailments and for general wellness purposes.
JohnCM
6 years ago
Tree of Knowledge products are on the cutting-edge of cannabis
Aug 12, 2016 By Joy Beckerman
There is nothing more inspiring than purpose-driven ingenuity.
One shining example is Tree of Knowledge, which combines the motivation to heal with applied science and business acumen. Co-founders Brian Main and Michael Caridi break into smiles when describing their EVR line of hemp-derived CBD products and the cutting-edge technology they’re developing (see sidebar).
Tree of Knowledge products
– Pharmacogenomic testing (genetic enzyme marking technology): This is a cheek swab test kit (sometimes known as a gene SNP kit) for health care practitioners that analyzes the genetic disposition of the patient for metabolic data. This information provides an indication of how the patient will metabolize various cannabinoids, including how various cannabinoids react with other medicines being taken by the patient. Interactions between certain medicines and cannabinoids can be problematic. Monitoring the rise or fall of enzyme levels can aid in the diagnosis of a variety of conditions. Knowing the metabolizer status of a patient helps practitioners in dosing and choosing a pharmaceutical strategy more effectively than the trial-and-error dosing models that are common practice.
-Nasal spray delivery technology: TOK is the exclusive licensee of this patented technology for CBD from cannabis. Nasal sprays are an effective delivery method, especially when rapid absorption is necessary, such as during an epileptic seizure. Nasal delivery may also assist with challenges related to poor bioavailability and gastrointestinal tract distress, while also avoiding the first-pass metabolism in the liver.
– Identification verification system: TOK has a licensing agreement for a state-of-the-art identification verification system created by a team of software developers in both the financial compliance and casino gaming arenas. The kiosk technology was created for the rapidly emerging sector of self-service, where terminals are capable of conducting transactions, but unable to verify government-issued identification. TOK’s kiosks also use biometric markers to enable a repeat use account to meet regulations.
– Vending kiosk: This system, which can incorporate identification verification, enables the payment of purchases at the kiosk by bridging the gap between live tellers and advanced cash handling machines. The system is uniquely focused on point-of-sale for hospitality and retail operations, where it can reduce lines, increase speed of self-service and reduce clerical errors. It also caters to consumers who do not wish to interact with a salesperson or cashier.
– EVR BrainBit EEG: The BrainBit is a small, wearable electroencephalography (EEG) device that monitors and records electrical activity of the brain. This data may be used to measure and compare brain activity before, during and after cannabinoid therapy. For example, brain activity can be measured during a seizure or PTSD event, and then measured again after treatment with cannabis to help determine the drug’s efficacy. Initial models will be designed for health care practitioners, but a personal use device is planned for release within 2016.
TOK’s product line includes premium hemp-derived CBD oil, tinctures, capsules and vape pens, all of which are produced under the highest manufacturing standards. Verified lab results can be accessed by a QR code, allowing consumers to view details about the precise lot and batch of the product they want to purchase.
The EVR products are derived from European industrial hemp cultivated through time-tested methods and processed under stringent regulations. All products are inspected and lab-tested prior to shipment. Cannabinoids are organic compounds that can break down or degrade if not stored properly, so all products are analyzed again when they arrive in the United States. TOK has U.S. and international distribution agreements in place, and its products can be purchased online.
TOK is far more than just a business venture. Main, a Northwest-born veteran and entrepreneur, met Caridi, a Northeast business development virtuoso, in 2010. They worked together on several real estate and investment projects, including the modernization of a hydropower plant in Montana where they installed new generators in existing dams.
In late 2010, Main was approached by a group looking to explore cannabis industry endeavors in New York. Main had already begun to focus on the non-euphoric aspects of cannabis after experiencing a horrific car accident that left him with pins in his shoulder and legs. He refused to rely on opioids, and years of living with the pain and severe headaches from those injuries left him feeling rusty and aged before his time. He found relief in cannabis, but as he grew older, he could no longer tolerate the euphoric effects of THC.
Brain Bit 2As Main explored CBD and non-euphoric cannabinoids to treat his own pain, he also began to study the effect of CBD on veterans suffering from PTSD, another condition that hits close to home for him. As Main and Caridi became increasingly encouraged by the peer-reviewed research and anecdotal evidence, they developed a joint mission to provide high-quality CBD products and to develop systems that will benefit the cannabis industry through technology.
“Because we believe in what we’re doing, we insist on delivering the highest standards in everything we do, and we have the experience and team to navigate the churning waters of cannabinoids quality of life,” Main says.
In addition to its EVR product line, TOK has heavily invested in the technology sector of the cannabis industry. The company formed an advisory board consisting of leaders from virtually every sector, ranging from medicine to professional sports to the military. The company’s strategic partners include nationally renowned scientists and researchers, as well as some of the top software developers in international financial compliance and casino gaming.
“Markets are controlled by systems that are in place,” Main says. “If a company wants to be relevant five years from now, then there must be a strong presence in the technology end.”
Given the outrageous barriers to formal research of cannabinoids, TOK sought out the leading experts in the field in order to ascertain the most reliable data available and create the first models of its diagnostic tools. Some of these tools have been created for health care practitioners in states that either allow or require providers to prescribe dosing instructions or other specific directions for cannabis patients.
Clarification
The company featured in this story, Tree of Knowledge, is incorporated as Tree of Knowledge, Inc. in Nevada and Tree of Kindness, Inc. in Washington.
Its only public website is www.evrcbd.com.
It is a completely separate organization from Tree of Knowledge, Inc. in Washington, which is a state-licensed cannabis producer (tokinc.com).
Joy Beckerman is the president of Hemp Ace International and president of the Washington chapter of the Hemp Industries Association. She is a member of Tree of Knowledge’s advisory board.
JohnCM
6 years ago
Tree Of Knowledge Announces Former Nespresso CEO and Global Consumer Brands Expert Appointed As New CEO
July 23, 2018
Toronto, Ontario (FSCwire) - Tree of Knowledge International Corp. (CSE:TOKI; OTC:TRKWF) (the “Company” or “TOK”) (formerly Courtland Capital Inc.) is pleased to announce that Mr. Jean-Paul Gaillard has joined the Company as its new Chief Executive Officer. Mr. Michael Caridi, the Company’s previous CEO, will remain as Chairman of the Board of Directors.
Mr. Gaillard’s experience includes six years in operational positions in the U.S. His primary focus is general management, marketing, finance and profit center responsibility honed from working with major multinationals such as Philip Morris Companies and Nestlé, as well as with medium-sized companies in industrial products and fast moving consumer goods. He is also highly experienced in managing special situations and strategic change.
Jean-Paul’s best known achievements include the creation and international expansion of the Marlboro Classics brand for Philip Morris, and the turnaround of Nespresso for the Nestlé Group.
At Philip Morris, he turned the Marlboro Classics brand into the unchallenged leader in its category, on par with the most successful competitors in this field. At Nespresso, starting with a business Nestlé had decided to close down following several unsuccessful attempts to succeed in the market, he took over as CEO. He defined and implemented a totally new business model which is still prevailing today and created the Nespresso Club.
He oversaw the development of an international group of companies, including overseeing all key agreements and negotiations with the machine partners such as Krups, as well as most current machine partners. His efforts were instrumental in making this business model into the worldwide success it became and continues today. This was done outside of the established Nestlé structure.
From a company with less than 10 people, he turned the business into a multinational group with a worldwide presence and exceptional growth. Nespresso ended up generating a multibillion turnover with some of the highest margins and ROIC in the food and beverage industry.
As CEO, he also oversaw the reorganization of Moevenpick’s Food Division and the acquisition of Ben & Jerry’s by Unilever. Moevenpick Ice Cream was subsequently bought by Nestlé. He was also instrumental in the sale of Ebel (LVMH) to the Movado Group (NYSE) and was also involved in the change of ownership of the Pilatus Aircraft company. Mr. Gaillard was also the founder and chairman of Ethical Coffee Company SA, which is the sole manufacturer of biodegradable coffee capsules, compatible with Nespresso machines.
Mr. Gaillard is currently the Chairman of Coventry Holding Group, a company specialized in M&A and special situations. Mr. Gaillard conducted his studies in Switzerland, England and the US, including 2 years in engineering and law. He also studied Business and Administration at the International Institute for Management Development (IMD) (SSE – Senior Level) in Lausanne/Switzerland, and at University of California, Los Angeles (UCLA).
Michael Caridi, Chairman of the Company stated: “The addition of Mr. Gaillard with his significant global brands and consumer goods experience will be extremely beneficial to the Company as we move forward with our goal of becoming a dominant global brand. He is an exciting addition to our executive leadership team with his demonstrated leadership abilities, vision for creating and launching new products, M&A and financing expertise. He has a remarkable track record for building global brands and we are excited to have him join our team.”
ABOUT TREE OF KNOWLEDGE
The Company produces and sells hemp-based cannabidiol (‘CBD”) products in certain jurisdictions in the United States, as well as in Europe, South America, Australia and China. Cannabidiol/CBD is a natural constituent of hemp which is purported to contain wellness properties. TOK’s CBD product line contains EVR Premium Hemp Oil, which is an organically grown and handled, gluten-free, vegan, non-GMO, synergistic compound that is derived from U.S. Department of Agriculture (USDA) approved industrial hemp grown in the United States. TOK currently offers several CBD products, which may be used in connection with the treatment of a number of ailments and for general wellness purposes.
JohnCM
6 years ago
Tree Of Knowledge International Corp. Announces World Renowned Dr. Sanjay Gupta Joins Advisory Board
July 18, 2018
Toronto, Ontario (FSCwire) - Tree of Knowledge International Corp. (CSE:TOKI; OTC:TRKWF) (the “Company” or “TOK”) (formerly Courtland Capital Inc.) is pleased to announce that world-renowned Dr. Sanjay Gupta has joined its world class Advisory Board.
Dr. Sanjay Gupta
Dr. Sanjay Gupta is perhaps one of the most well-known medical professionals worldwide, and is one of the most recognized and influential leaders in his field. In addition to serving as President of DrCircle.com, he has appeared on various television platforms and as the Director of Health Time TV, comprised of more than 160,000 medical professionals. He is a Harvard trained pain specialist and President of the American Pain Association, as well as an outspoken proponent of medical marijuana and it’s role in fighting the opioid epidemic. He has received several awards including Top Docs Awards, Michiganian of the Year Award and Best resident physician Award.
Dr. Gupta joins Dr. Michael Smatt, Joy Beckerman, Christopher Kaplan and Ambassador Jack Brewer on the Company’s Advisory Board. The mandate of the Advisory Board is to serve as a strategic resource for the Company to advise on healthcare outreach initiatives surrounding CBD and the furtherance of educating both patients and athletes and support the Company’s overall mission.
Michael Caridi, Chairman and CEO of the Company stated: “We have truly built a world class advisory board with the addition of Dr. Sanjay Gupta. His leadership, knowledge and influence will be a tremendous asset to the Company. Each of our Advisory Members brings specialized talents, skills and influence which will be instrumental in the Company achieving its goals of becoming a dominant global brand. Having someone such as Dr. Gupta join our Advisory Board speaks volumes and reinforces our commitment to creating best in class products and being at the forefront in innovation in this rapidly evolving field.”
ABOUT TREE OF KNOWLEDGE
The Company produces and sells hemp-based cannabidiol (‘CBD”) products in certain jurisdictions in the United States, as well as in Europe, South America, Australia and China. Cannabidiol/CBD is a natural constituent of hemp which is purported to contain wellness properties. TOK’s CBD product line contains EVR Premium Hemp Oil, which is an organically grown and handled, gluten-free, vegan, non-GMO, synergistic compound that is derived from U.S. Department of Agriculture (USDA) approved industrial hemp grown in the United States. TOK currently offers several CBD products, which may be used in connection with the treatment of a number of ailments and for general wellness purposes.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Ask ADVFN Intelligence (AI)
Nosnibor
3 years ago
Golden Cross
4 years ago
BlueGreenPower
6 years ago
Hot Features
Premium
